Entities / Company
Biofrontera.
Company
- Reports this week
- 0
- Active events
- 0
- Connections
- 12
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
-
Biofrontera and Inhibikase Therapeutics are both identified as small-cap healthcare companies.Some support1 report
-
A hedge fund filed documents with the US SEC regarding Biofrontera.Some support1 report
-
Geode Capital Management raised its position in Biofrontera stock on August 30, 2026.Some support1 report
Gone quiet
No new reports in 90+ days-
Biofrontera's acquisition of George Jones includes rights to FDA approval and strengthens commercial efforts.Some support1 report1 development inside
-
Biofrontera commercializes its products in the US market.Some support1 report
-
Biofrontera started using LinkedIn for company following.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Biofrontera this week
News at the entities that move Biofrontera most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Biofrontera
-
Geode Capital Management TransactionalGeode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Moves Biofrontera
-
LinkedIn Mentioned togetherBoth LinkedIn and Google are currently being utilized as platforms for news distribution.Moves Biofrontera
-
Arcturus Therapeutics Mentioned togetherArcturus Therapeutics' products are being used in Europe as a patient market for OTC deficiency.Moves Biofrontera
Connections
The 4 strongest of 12, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
FDA regulates Biofrontera's drug development, validating safety and granting approval rights.
-
Geode Capital Management Transactional
Geode Capital Management raised its position in Biofrontera stock.
-
LinkedIn Mentioned together
Biofrontera utilizes LinkedIn for professional presence and company following.
-
Arcturus Therapeutics Mentioned together
The two companies are co-mentioned as part of the biotech sector experiencing rating changes.